Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Sun Yat-sen University · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
adverse-effectchemotherapyefficacy
recurrent nasopharyngeal carcinoma, pd-1 antibody, intensity-modulated radiation therapy, efficacy, adverse effect, chemotherapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 883252
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.